Related Experiment Video
Updated: Jul 14, 2026
11:02
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.5K
Expression and Clinical Significance of MMP-28 in Bladder Cancer
Heng Wang1, Jun-Xiu Wu2, Xin-Peng Chen1
1Graduate Department, 74539Bengbu Medical College, Bengbu, China.
Technology in Cancer Research & Treatment
|November 16, 2020
Summary
Matrix metalloproteinase-28 (MMP-28) is upregulated in bladder cancer, correlating with advanced disease and poorer prognosis. This finding suggests MMP-28 as a potential diagnostic and prognostic biomarker for urothelial carcinoma.
Area of Science:
- Oncology
- Molecular Biology
- Urology
Background:
- Bladder urothelial carcinoma is a significant health concern.
- Understanding molecular markers for diagnosis and prognosis is crucial.
Purpose of the Study:
- To determine matrix metalloproteinase-28 (MMP-28) expression in bladder cancer.
- To analyze the correlation of MMP-28 with clinicopathological characteristics and patient prognosis.
Main Methods:
- Immunohistochemistry was performed on 491 bladder cancer samples and 80 adjacent normal tissues.
- MMP-28 expression levels were quantified.
- Correlation with clinicopathological features and survival was assessed.
Main Results:
- MMP-28 expression was significantly higher in bladder cancer than in normal tissues.
- High MMP-28 levels correlated with advanced tumor grade, lymphatic invasion, lymph node metastasis, and distant metastasis.
- Upregulated MMP-28 was associated with increased cancer progression risk and decreased overall survival.
Conclusions:
- Abnormal MMP-28 expression may contribute to urothelial carcinoma initiation and progression.
- MMP-28 upregulation serves as a potential indicator for diagnosing bladder cancer and predicting tumor progression.
